We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Jury Bats Down Synthon’s Claim Against Pfizer

Law360 (August 18, 2006, 12:00 AM EDT) -- In another victory for brand name drug companies, a federal jury has rejected Dutch generics maker Synthon IP Inc.’s claim that Pfizer Inc.’s blockbuster blood pressure drug Norvasc violates its intellectual...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.